On the other hand, a very recent research reported that glioblastoma (GBM) patients survival are negatively correlated with TRPML1 expression level, while glioma cells are vulnerable to ROS when TRPML1 is activated [60]. The gene discussed is MCOLN1; the disease is central nervous system cancer.